Boston, MA -- (SBWIRE) -- 07/11/2012 -- Kuros Biosurgery AG (Kuros) is a biomedical company engaged in the development of biomaterial products. It develops a broad range of bioactive wound care products, bone graft substitutes and bioactive spinal products. The company's hard and soft tissue repair products are used in biosurgery and orthobiologics markets. Kuros developed a broad pipeline of products that are currently at various stages of clinical and pre-clinical development within the core areas of trauma, wound and spine. Kuros has two biomaterial technology platforms, one based on fibrin sealants and the other based on its own proprietary synthetic technology. Kuros is headquartered in Zurich, Switzerland

This report is a source for data, analysis and actionable intelligence on the Kuros Biosurgery AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

View Full Report Details and Table of Contents

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Epigenomics AG (ECX) - Product Pipeline Analysis
- Bayer HealthCare AG - Product Pipeline Analysis
- Nobel Biocare Holding AG (NOBN) - Product Pipeline Analysis
- aap Implantate AG (AAQ) - Product Pipeline Analysis
- Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis
- Siemens Healthcare - Product Pipeline Analysis
- Siemens Healthcare Diagnostics, Inc. - Product Pipeline Analysis
- Kuros Biosurgery AG - Product Pipeline Review - 2012
- Kuros Biosurgery AG - Product Pipeline Review - H2 2011